Article Details
Retrieved on: 2021-04-19 13:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Synlogic (Nasdaq: SYBX) a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the pricing ...
Article found on: investchronicle.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here